Explore more topics
SEC reporting owner

Crane Alan L SEC insider disclosures

Explore Crane Alan L's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-12T05:54:58.330Z

Reporting owner CIK
0001294361
Issuers
7
Coverage
verified
Jump to a section

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Scroll sideways to compare all columns. Select a heading to sort.

MOMENTA PHARMACEUTICALS INC0001235010MNTAYesYes
Sirtris Pharmaceuticals, Inc.0001388775SIRTNoYes
Cerulean Pharma Inc.0001401914CERUNoYes
OCULAR THERAPEUTIX, INC0001393434OCULNoYes
T2 Biosystems, Inc.0001492674TTOONoYes
VACCINEX, INC.0001205922VCNXNoYes
Pandion Therapeutics, Inc.0001807901PANDNoYes

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.